Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02355873

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02355873
Other papers using this trial's data
  • Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study BMC nephrology, 2017-06-30 DOI, PubMed 28666474, PMC5493884 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02355873. Randomized; double masking; primary purpose treatment. Start 2015-02 (actual); primary completion 2015-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
Condition
Critical Ill Patients
Condition
Patients Needing Continuous Renal Replacement Therapy
Intervention (Device)
AN69ST hemofilter
Intervention (Device)
AN69 hemofilter
Lead sponsor
Peking University First Hospital (class: other)

Record details

Record id
cardio:ct-nct02355873
Content hash
1215f6f945e063a5d4fdcd9d57d725098bc180e054ad0330d904b7c25bebac43